CD8A and non-small cell lung carcinoma: In particular, human DC3s have been identified as a CD1c+ dendritic cell subset distinct from cDC2s and to be enriched in NSCLC tumors, and have been suggested to uniquely prime tissue-resident CD8+ T cells27,40–43.